Pyrimidine compounds

Details Pyrimidine compounds Pyrimidine compounds

2006-11-21

2009-12-29

Rao, Deepak (Department: 1624)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C514S260100, C514S266300, C514S274000, C544S253000, C544S278000, C544S285000, C544S310000, C544S311000

Reexamination Certificate

active

07638520

ABSTRACT:
Pyrimidone compounds of formula (I):are inhibitors of the enzyme Lp-PLA2and are of use in treating atheroscelerosis.

REFERENCES:
patent: 6649619 (2003-11-01), Leach et al.
patent: 7153861 (2006-12-01), Leach et al.
patent: 7470694 (2008-12-01), Leach et al.
patent: WO 99/24420 (1999-05-01), None
patent: WO 00/66567 (2000-11-01), None
Hickey, et al. Chemical Abstracts, vol. 135 entry 195570, 2001.
Lerman, Women and Ischemia Syndrome Evaluation (WISE) Diagnosis and Pathophysiology of Ischemic Heart Disease Workshop. Oct. 2002.
Koren, Diastolic Congestive Hearl Failure, Jacksonville Medicine. Feb. 2002.
Lribarren et at., Association of Lipoprotein-Associated Phospholipase A2 Mass and Activity with Calcified Coronary Plaque in Young Adults, Arterioscler Thromb Vasc Biol., 25:216-221, Jan. 2005.
I McAllister et al., Randomised trials of secondary prevention programmes in coronary heart disease: systematic review, BMJ, vol. 323, pp. 957-962, Oct. 2001.

Affiliated with

Also associated with

Rating

Pyrimidine compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pyrimidine compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrimidine compounds will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4063751